Science, medicine, and the future: Obesity treatment

BMJ 1997; 315 doi: (Published 13 December 1997) Cite this as: BMJ 1997;315:1599

An author's error occurred in this article by John Wilding (18 October, pp 997-1000). In the first paragraph on page 998 it was wrongly stated that no drug is licensed for treating obesity in Britain. In fact, phentermine is still licensed for use, but it is not recommended for the routine management of obesity.

View Abstract